Statins, Cholesterol and Cognitive Decline in Alzheimer's

CompletedOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2025

Conditions

Alzheimer DementiaStatins

Interventions

DRUG

STA 4783

Use of statins will be identified from Prescribed Drug register within 6 months before dementia diagnosis or each follow-up date

Trial Locations (1)

Karolinska Institutet, Stockholm

All Listed Sponsors

collaborator

Region Stockholm

OTHER_GOV

lead

Karolinska Institutet

OTHER

NCT06635252 - Statins, Cholesterol and Cognitive Decline in Alzheimer's | Biotech Hunter | Biotech Hunter